Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis

NCT00294775 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Aortic Valve Stenosis
Left Ventricular Hypertrophy
Atrial Fibrillation

Interventions

DRUG: Candesartan

Sponsor

Odense University Hospital